Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | -4.24% | -1.86% | -14.13% |
21/05 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
13/05 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.13% | 23Cr | |
-18.39% | 852.76Cr | |
+65.89% | 426.14Cr | |
+6.21% | 271.18Cr | |
-1.93% | 263.46Cr | |
-57.14% | 171.66Cr | |
-19.16% | 167.05Cr | |
-20.01% | 144.66Cr | |
+15.38% | 118.85Cr | |
-50.40% | 101.08Cr |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024